Skip to content
Optellum
  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case studies
    • Clinical Validation
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales
Menu Close
  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case studies
    • Clinical Validation
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales

News & Events

Read more about the article Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative

Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative

  • Post published:August 23, 2021
  • Post category:Media

Founded in 2012, HIT Consultant is the leading source of healthcare technology news, analysis and insights for healthcare executives, physicians, and providers. Our content provides editorial insights on health IT,…

Continue ReadingOptellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative
Read more about the article Optellum Joins J&J’s Lung Cancer Initiative

Optellum Joins J&J’s Lung Cancer Initiative

  • Post published:August 23, 2021
  • Post category:Media

Reporter: Reed Miller reed.miller@informa.comMedTech Insight

Continue ReadingOptellum Joins J&J’s Lung Cancer Initiative
Read more about the article Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment

Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment

  • Post published:August 20, 2021
  • Post category:Media

Today UK News Reporter: Debbie Casey

Continue ReadingOptellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment
Read more about the article EIT Health-supported Optellum partners with J&J

EIT Health-supported Optellum partners with J&J

  • Post published:August 20, 2021
  • Post category:Media

EIT Health

Continue ReadingEIT Health-supported Optellum partners with J&J
Read more about the article Health Tech Digital: Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment

Health Tech Digital: Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment

  • Post published:August 20, 2021
  • Post category:Media

Health Tech Digital

Continue ReadingHealth Tech Digital: Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment
Read more about the article Emintera: Optellum announces strategic collaboration with Johnson & Johnson’s Lung Cancer Initiative to apply AI to transform early lung cancer treatment

Emintera: Optellum announces strategic collaboration with Johnson & Johnson’s Lung Cancer Initiative to apply AI to transform early lung cancer treatment

  • Post published:August 20, 2021
  • Post category:Media

Emintera

Continue ReadingEmintera: Optellum announces strategic collaboration with Johnson & Johnson’s Lung Cancer Initiative to apply AI to transform early lung cancer treatment
Read more about the article Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment

Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment

  • Post published:August 20, 2021
  • Post category:Media

Healthcare Newsdesk brings the latest UK Healthcare News to you by NTS.Healthcare Newsdesk

Continue ReadingOptellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment
Read more about the article J&J partners with AI startup to identify early lung cancer cases

J&J partners with AI startup to identify early lung cancer cases

  • Post published:August 19, 2021
  • Post category:Media

Modern Healthcare is the industry's leading source of healthcare business and policy news, research and information. We report on important healthcare events and trends, as they happen, through our print…

Continue ReadingJ&J partners with AI startup to identify early lung cancer cases
Read more about the article First Edition: Aug. 19, 2021

First Edition: Aug. 19, 2021

  • Post published:August 19, 2021
  • Post category:Media

Summaries of health policy coverage from major news organizationsKaiser Health News

Continue ReadingFirst Edition: Aug. 19, 2021
Read more about the article AI-optimized health startup with HQ in Houston takes its tech to the next level with new partner

AI-optimized health startup with HQ in Houston takes its tech to the next level with new partner

  • Post published:August 19, 2021
  • Post category:Media

InnovationMap shines a spotlight on innovation in Houston within startups, tech, health, energy, social impact, and more. We profile leaders within the industry as Featured Innovators and feature thought leadership…

Continue ReadingAI-optimized health startup with HQ in Houston takes its tech to the next level with new partner
Read more about the article Client company Optellum announces strategic collaboration with Johnson & Johnson

Client company Optellum announces strategic collaboration with Johnson & Johnson

  • Post published:August 19, 2021
  • Post category:Media

The Oxford Trust is an independent charitable trust that was established in 1985 by Oxford entrepreneurs Sir Martin and Lady Audrey Wood, founders of Oxford Instruments.The Oxford Trust

Continue ReadingClient company Optellum announces strategic collaboration with Johnson & Johnson
Read more about the article Optellum collaborating with Johnson & Johnson

Optellum collaborating with Johnson & Johnson

  • Post published:August 19, 2021
  • Post category:Media

The National Consortium of Intelligent Medical Imaging (NCIMI) is revolutionising healthcare through Artificial Intelligence (AI). We are a partnership between NHS trusts, companies, universities, charities and patient groups coordinated by…

Continue ReadingOptellum collaborating with Johnson & Johnson
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Go to the next page

Optellum Ltd.

  • Oxford Centre for Innovation
    Oxford, OX1 1BY
    United Kingdom
  • info@optellum.comOpens in your application

Optellum Inc.

  • TMC Innovation Institute
    2450 Holcombe Blvd, Suite X
    Houston, TX 77021
    United States

Pages

  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case studies
    • Clinical Validation
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales

Follow Us

  • Opens in a new tab
  • Opens in a new tab

Certifications

Copyright 2023 - Optellum Ltd | Privacy Policy
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}